Label-Free Screening Now Available for Standard Microtiter Plate Readers

A high performance set of label-free screening tools based on surface plasmon resonance (SPR) technology that does not require expensive special equipment is now available to researchers and drug developers.

The technology, represented by the PharmaDiagnostics (Zellik, Belgium) SoPRano line of reagents, is based on ligand-coated colloidal gold nanoparticles. A major advance is that these reagents can be used in standard 96-well microtiter plates and read on the plate readers already found in most biotechnology laboratories. The reagents are complemented by easy-to-use protocols and are applicable to a wide range of assays for both small molecule and antibody screening and characterization.

"With SoPRano, PharmaDiagnostics is providing label-free screening for a much broader range of researchers,” said Dr. David Ricketts, CEO of PharmaDiagnostics. "Early customer feedback has been extremely positive. This product launch and our new corporate website and online SoPRano facility demonstrate PharmaDiagnostics' commitment to develop and enhance SoPRano and bring our customers real value. After our recent USD 3.5 million fundraising, the launch of SoPRano is another significant step forward in the development of PharmaDiagnostics' business.”

Related Links:
PharmaDiagnostics